Pfizer is currently making the case for approval of its rheumatoid arthritis pill to the FDA Advisory Panel, reports CNBC's Seema Mody.
Related Links:
Business & financial news headlines from msnbc.com
Top of page
one life to live jeff fisher van der sloot heather locklear mlk memorial mlk memorial heather locklear hospitalized
No comments:
Post a Comment